Speaker: Markus Zeitlinger, Head of Department, Department of Clinical Pharmacology, Medical University of Vienna (Austria)

Moderator: Markus Heep, Medical Lead Zoliflodacin programme, GARDP (Switzerland)

In this webinar, Markus Zeitlinger gave an overview of different goals of phase 1 studies of antibiotic drug development.

Topics discussed included:

  • Combination of several aims in one study
  • What do I need to extrapolate antimicrobial efficacy based on phase 1
  • Most frequent questions during scientific advice

This live webinar including interactive Q&A session was broadcast on 30 June 2020.

If you have questions or comments, please let us know: revive@gardp.org.